These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29155507)

  • 1. The role of radiation therapy in the modern management of oligometastatic disease.
    Li Y; Tao S; Li M; Li D
    J BUON; 2017; 22(4):831-837. PubMed ID: 29155507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligometastatic disease, the curative challenge in radiation oncology.
    Palacios-Eito A; García-Cabezas S
    World J Clin Oncol; 2015 Aug; 6(4):30-4. PubMed ID: 26266098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic radiotherapy in oligometastatic cancer.
    Kennedy TAC; Corkum MT; Louie AV
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S16. PubMed ID: 28917254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer.
    Shultz DB; Filippi AR; Thariat J; Mornex F; Loo BW; Ricardi U
    J Thorac Oncol; 2014 Oct; 9(10):1426-33. PubMed ID: 25170641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local ablative stereotactic body radiotherapy for oligometastatic prostate cancer.
    Niazi T; Elakshar S; Stroian G
    Curr Opin Support Palliat Care; 2018 Sep; 12(3):351-358. PubMed ID: 29979320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.
    Desai NB; Laine AM; Timmerman RD
    Br J Radiol; 2017 Feb; 90(1070):20160500. PubMed ID: 28008774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
    Juan O; Popat S
    Clin Lung Cancer; 2017 Nov; 18(6):595-606. PubMed ID: 28377206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multinational report of technical factors on stereotactic body radiotherapy for oligometastases.
    Redmond KJ; Lo SS; Dagan R; Poon I; Foote MC; Erler D; Lee Y; Lohr F; Biswas T; Ricardi U; Sahgal A
    Future Oncol; 2017 May; 13(12):1081-1089. PubMed ID: 28152619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stereotactic body radiation therapy and oligometastases].
    Bourgier C; Azria D; Fenoglietto P; Riou O; Almaghrabi MY; Supiot S; Mornex F; Giraud P
    Cancer Radiother; 2014; 18(4):337-41. PubMed ID: 24792996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiotherapy for oligometastatic disease.
    Hanna GG; Landau D
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):290-7. PubMed ID: 25770653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Improvements of ablative local treatments modify the management of the oligometastatic disease].
    Thariat J; Vignot S; Bensadoun RJ; Mornex F
    Cancer Radiother; 2012 Sep; 16(5-6):325-9. PubMed ID: 22784592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy.
    Blanchard M; Shim KG; Grams MP; Rajani K; Diaz RM; Furutani KM; Thompson J; Olivier KR; Park SS; Markovic SN; Pandha H; Melcher A; Harrington K; Zaidi S; Vile R
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):577-87. PubMed ID: 26461000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Strategies in Stereotactic Radiotherapy for Oligometastases.
    Palma DA; Louie AV; Rodrigues GB
    Clin Cancer Res; 2015 Dec; 21(23):5198-204. PubMed ID: 26626571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial.
    Trovo M; Furlan C; Polesel J; Fiorica F; Arcangeli S; Giaj-Levra N; Alongi F; Del Conte A; Militello L; Muraro E; Martorelli D; Spazzapan S; Berretta M
    Radiother Oncol; 2018 Jan; 126(1):177-180. PubMed ID: 28943046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
    Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
    Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiotherapy in metastatic breast cancer.
    Possanzini M; Greco C
    Breast; 2018 Oct; 41():57-66. PubMed ID: 30007269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic Body Radiotherapy - Current Indications.
    Burkoň P; Slavik M; Kazda T; Pospíšil P; Prochazka T; Vrzal M; Šlampa P
    Klin Onkol; 2019; 32(1):10-24. PubMed ID: 30894002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy for oligometastatic non-small cell lung cancer.
    Salama JK; Schild SE
    Cancer Metastasis Rev; 2015 Jun; 34(2):183-93. PubMed ID: 25948377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: What do we know and where are we going?
    Hong JC; Salama JK
    Cancer Treat Rev; 2017 Jan; 52():22-32. PubMed ID: 27886588
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.